nodes	percent_of_prediction	percent_of_DWPC	metapath
Cytarabine—POLD1—mouth—autistic disorder	0.0182	0.0588	CbGeAlD
Cytarabine—POLB—telencephalon—autistic disorder	0.0129	0.0417	CbGeAlD
Cytarabine—DCTD—eye—autistic disorder	0.0114	0.0369	CbGeAlD
Cytarabine—DCTD—forebrain—autistic disorder	0.0113	0.0366	CbGeAlD
Cytarabine—DCTD—telencephalon—autistic disorder	0.0104	0.0336	CbGeAlD
Cytarabine—NT5E—eye—autistic disorder	0.00885	0.0285	CbGeAlD
Cytarabine—POLD1—digestive system—autistic disorder	0.00807	0.026	CbGeAlD
Cytarabine—NT5E—telencephalon—autistic disorder	0.00807	0.026	CbGeAlD
Cytarabine—POLB—head—autistic disorder	0.00806	0.026	CbGeAlD
Cytarabine—DCTD—digestive system—autistic disorder	0.00796	0.0257	CbGeAlD
Cytarabine—POLB—nervous system—autistic disorder	0.00764	0.0246	CbGeAlD
Cytarabine—POLB—central nervous system—autistic disorder	0.00735	0.0237	CbGeAlD
Cytarabine—POLB—cerebellum—autistic disorder	0.00719	0.0232	CbGeAlD
Cytarabine—POLD1—head—autistic disorder	0.00658	0.0212	CbGeAlD
Cytarabine—DCTD—head—autistic disorder	0.00649	0.0209	CbGeAlD
Cytarabine—DCTD—nervous system—autistic disorder	0.00616	0.0199	CbGeAlD
Cytarabine—POLE—digestive system—autistic disorder	0.00603	0.0195	CbGeAlD
Cytarabine—DCTD—central nervous system—autistic disorder	0.00593	0.0191	CbGeAlD
Cytarabine—POLD1—cerebellum—autistic disorder	0.00587	0.0189	CbGeAlD
Cytarabine—POLB—brain—autistic disorder	0.00584	0.0188	CbGeAlD
Cytarabine—DCTD—cerebellum—autistic disorder	0.00579	0.0187	CbGeAlD
Cytarabine—NT5E—head—autistic disorder	0.00502	0.0162	CbGeAlD
Cytarabine—POLE—head—autistic disorder	0.00492	0.0159	CbGeAlD
Cytarabine—SLC29A1—forebrain—autistic disorder	0.00478	0.0154	CbGeAlD
Cytarabine—Nelarabine—ADA—autistic disorder	0.00477	0.239	CrCbGaD
Cytarabine—POLD1—brain—autistic disorder	0.00477	0.0154	CbGeAlD
Cytarabine—NT5E—nervous system—autistic disorder	0.00476	0.0154	CbGeAlD
Cytarabine—DCTD—brain—autistic disorder	0.00471	0.0152	CbGeAlD
Cytarabine—POLE—nervous system—autistic disorder	0.00467	0.015	CbGeAlD
Cytarabine—NT5E—central nervous system—autistic disorder	0.00459	0.0148	CbGeAlD
Cytarabine—Vidarabine—ADA—autistic disorder	0.00453	0.226	CrCbGaD
Cytarabine—POLE—central nervous system—autistic disorder	0.00449	0.0145	CbGeAlD
Cytarabine—SLC29A1—telencephalon—autistic disorder	0.0044	0.0142	CbGeAlD
Cytarabine—POLE—cerebellum—autistic disorder	0.00439	0.0142	CbGeAlD
Cytarabine—DCK—telencephalon—autistic disorder	0.0042	0.0135	CbGeAlD
Cytarabine—ABCC10—telencephalon—autistic disorder	0.004	0.0129	CbGeAlD
Cytarabine—SLC22A1—forebrain—autistic disorder	0.0039	0.0126	CbGeAlD
Cytarabine—SLC22A2—digestive system—autistic disorder	0.00387	0.0125	CbGeAlD
Cytarabine—Glucosamine—IFNG—autistic disorder	0.00385	0.193	CrCbGaD
Cytarabine—POLA1—cerebellum—autistic disorder	0.00378	0.0122	CbGeAlD
Cytarabine—NT5E—brain—autistic disorder	0.00364	0.0117	CbGeAlD
Cytarabine—Adenosine—ADA—autistic disorder	0.00362	0.181	CrCbGaD
Cytarabine—SLC22A1—telencephalon—autistic disorder	0.00358	0.0115	CbGeAlD
Cytarabine—POLE—brain—autistic disorder	0.00357	0.0115	CbGeAlD
Cytarabine—SLC29A1—digestive system—autistic disorder	0.00336	0.0108	CbGeAlD
Cytarabine—DCK—digestive system—autistic disorder	0.00321	0.0103	CbGeAlD
Cytarabine—POLA1—brain—autistic disorder	0.00307	0.00991	CbGeAlD
Cytarabine—ABCC10—digestive system—autistic disorder	0.00305	0.00985	CbGeAlD
Cytarabine—SLC29A1—head—autistic disorder	0.00274	0.00883	CbGeAlD
Cytarabine—DCK—head—autistic disorder	0.00262	0.00843	CbGeAlD
Cytarabine—SLC29A1—nervous system—autistic disorder	0.0026	0.00837	CbGeAlD
Cytarabine—SLC29A1—central nervous system—autistic disorder	0.0025	0.00806	CbGeAlD
Cytarabine—DCK—nervous system—autistic disorder	0.00248	0.00799	CbGeAlD
Cytarabine—SLC29A1—cerebellum—autistic disorder	0.00244	0.00788	CbGeAlD
Cytarabine—DCK—central nervous system—autistic disorder	0.00239	0.0077	CbGeAlD
Cytarabine—DCK—cerebellum—autistic disorder	0.00233	0.00752	CbGeAlD
Cytarabine—SLC22A1—head—autistic disorder	0.00223	0.00719	CbGeAlD
Cytarabine—ABCC10—cerebellum—autistic disorder	0.00222	0.00717	CbGeAlD
Cytarabine—SLC22A1—nervous system—autistic disorder	0.00211	0.00682	CbGeAlD
Cytarabine—SLC22A1—central nervous system—autistic disorder	0.00204	0.00656	CbGeAlD
Cytarabine—SLC29A1—brain—autistic disorder	0.00198	0.0064	CbGeAlD
Cytarabine—DCK—brain—autistic disorder	0.0019	0.00611	CbGeAlD
Cytarabine—S-Adenosylmethionine—COMT—autistic disorder	0.00183	0.0915	CrCbGaD
Cytarabine—ABCC10—brain—autistic disorder	0.00181	0.00582	CbGeAlD
Cytarabine—SLC22A1—brain—autistic disorder	0.00162	0.00521	CbGeAlD
Cytarabine—Adenosine monophosphate—PDE4B—autistic disorder	0.00139	0.0696	CrCbGaD
Cytarabine—CYP3A4—digestive system—autistic disorder	0.00125	0.00402	CbGeAlD
Cytarabine—CYP3A4—nervous system—autistic disorder	0.000964	0.00311	CbGeAlD
Cytarabine—CYP3A4—central nervous system—autistic disorder	0.000928	0.00299	CbGeAlD
Cytarabine—SLC22A1—Transmission across Chemical Synapses—MAOA—autistic disorder	0.000126	0.000188	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—PRKCB—autistic disorder	0.000126	0.000188	CbGpPWpGaD
Cytarabine—DCK—Metabolism—RORA—autistic disorder	0.000126	0.000188	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—MAOB—autistic disorder	0.000125	0.000187	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—COMT—autistic disorder	0.000125	0.000186	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—GSTP1—autistic disorder	0.000124	0.000185	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—MAOA—autistic disorder	0.000124	0.000185	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—ACADSB—autistic disorder	0.000123	0.000183	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—INPP1—autistic disorder	0.000123	0.000183	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—GABRB3—autistic disorder	0.000123	0.000183	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—GABRA1—autistic disorder	0.000123	0.000183	CbGpPWpGaD
Cytarabine—CDA—Metabolism—CYP19A1—autistic disorder	0.000123	0.000183	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—CAT—autistic disorder	0.000121	0.00018	CbGpPWpGaD
Cytarabine—POLA1—Mitotic M-M/G1 phases—PRKCB—autistic disorder	0.00012	0.000179	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—DLG4—autistic disorder	0.000119	0.000177	CbGpPWpGaD
Cytarabine—DCK—Metabolism—MAOB—autistic disorder	0.000118	0.000176	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—autistic disorder	0.000118	0.000175	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—BTD—autistic disorder	0.000117	0.000175	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—GABRB2—autistic disorder	0.000117	0.000174	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—GABRA2—autistic disorder	0.000117	0.000174	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—PRKCB—autistic disorder	0.000117	0.000174	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—TPH2—autistic disorder	0.000117	0.000174	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—DPYD—autistic disorder	0.000115	0.000171	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PLA2G4A—autistic disorder	0.000114	0.00017	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—GSTM1—autistic disorder	0.000114	0.00017	CbGpPWpGaD
Cytarabine—CDA—Metabolism—COMT—autistic disorder	0.000114	0.00017	CbGpPWpGaD
Cytarabine—CDA—Metabolism—GSTP1—autistic disorder	0.000113	0.000169	CbGpPWpGaD
Cytarabine—CDA—Metabolism—MAOA—autistic disorder	0.000113	0.000169	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—PRKCB—autistic disorder	0.000113	0.000168	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PTGS2—autistic disorder	0.000112	0.000167	CbGpPWpGaD
Cytarabine—CDA—Metabolism—CAT—autistic disorder	0.00011	0.000165	CbGpPWpGaD
Cytarabine—DCK—Metabolism—TPH2—autistic disorder	0.00011	0.000164	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—BTD—autistic disorder	0.000109	0.000163	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—GPX1—autistic disorder	0.000109	0.000163	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—GABRA2—autistic disorder	0.000109	0.000162	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—GABRB2—autistic disorder	0.000109	0.000162	CbGpPWpGaD
Cytarabine—DCK—Metabolism—DPYD—autistic disorder	0.000108	0.000161	CbGpPWpGaD
Cytarabine—SLC22A2—SLC-mediated transmembrane transport—AVP—autistic disorder	0.000108	0.000161	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—CACNA1C—autistic disorder	0.000107	0.000159	CbGpPWpGaD
Cytarabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—autistic disorder	0.000105	0.000157	CbGpPWpGaD
Cytarabine—SLC22A2—Neuronal System—COMT—autistic disorder	0.000104	0.000156	CbGpPWpGaD
Cytarabine—CDA—Metabolism—GSTM1—autistic disorder	0.000104	0.000156	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PLA2G4A—autistic disorder	0.000104	0.000156	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—SLC1A3—autistic disorder	0.000104	0.000155	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—AQP4—autistic disorder	0.000104	0.000155	CbGpPWpGaD
Cytarabine—SLC22A2—Neuronal System—MAOA—autistic disorder	0.000104	0.000155	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—MTHFR—autistic disorder	0.000101	0.00015	CbGpPWpGaD
Cytarabine—DCK—Metabolism—CACNA1C—autistic disorder	0.0001	0.00015	CbGpPWpGaD
Cytarabine—SLC22A1—SLC-mediated transmembrane transport—AVP—autistic disorder	0.0001	0.00015	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—TDO2—autistic disorder	9.98e-05	0.000149	CbGpPWpGaD
Cytarabine—CDA—Metabolism—GPX1—autistic disorder	9.98e-05	0.000149	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PTEN—autistic disorder	9.75e-05	0.000146	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—COMT—autistic disorder	9.74e-05	0.000145	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—DHFR—autistic disorder	9.7e-05	0.000145	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—SLC1A3—autistic disorder	9.7e-05	0.000145	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—AQP4—autistic disorder	9.7e-05	0.000145	CbGpPWpGaD
Cytarabine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—autistic disorder	9.68e-05	0.000144	CbGpPWpGaD
Cytarabine—SLC22A2—Transmission across Chemical Synapses—PRKCB—autistic disorder	9.68e-05	0.000144	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—MAOA—autistic disorder	9.67e-05	0.000144	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK1—autistic disorder	9.56e-05	0.000143	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—DHCR7—autistic disorder	9.38e-05	0.00014	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—APOE—autistic disorder	9.37e-05	0.00014	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—TDO2—autistic disorder	9.3e-05	0.000139	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—CP—autistic disorder	9.27e-05	0.000138	CbGpPWpGaD
Cytarabine—CDA—Metabolism—MTHFR—autistic disorder	9.21e-05	0.000137	CbGpPWpGaD
Cytarabine—CYP3A4—Biological oxidations—MAOB—autistic disorder	9.19e-05	0.000137	CbGpPWpGaD
Cytarabine—DCK—Metabolism—DHFR—autistic disorder	9.12e-05	0.000136	CbGpPWpGaD
Cytarabine—SLC22A1—Transmission across Chemical Synapses—PRKCB—autistic disorder	9.02e-05	0.000135	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—PRKCB—autistic disorder	8.98e-05	0.000134	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—EXT1—autistic disorder	8.89e-05	0.000133	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—SLC6A8—autistic disorder	8.89e-05	0.000133	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—DHCR7—autistic disorder	8.74e-05	0.000131	CbGpPWpGaD
Cytarabine—POLE—Mitotic M-M/G1 phases—MAPK1—autistic disorder	8.68e-05	0.00013	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—CP—autistic disorder	8.64e-05	0.000129	CbGpPWpGaD
Cytarabine—CDA—Metabolism—APOE—autistic disorder	8.57e-05	0.000128	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—DAO—autistic disorder	8.48e-05	0.000127	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PIK3CG—autistic disorder	8.46e-05	0.000126	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—EXT1—autistic disorder	8.29e-05	0.000124	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—SLC6A8—autistic disorder	8.29e-05	0.000124	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—UPB1—autistic disorder	8.13e-05	0.000121	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—POMC—autistic disorder	8.05e-05	0.00012	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—PRKCB—autistic disorder	8.03e-05	0.00012	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—DAO—autistic disorder	7.91e-05	0.000118	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—TF—autistic disorder	7.88e-05	0.000118	CbGpPWpGaD
Cytarabine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—autistic disorder	7.77e-05	0.000116	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PIK3CG—autistic disorder	7.74e-05	0.000115	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—CYP19A1—autistic disorder	7.6e-05	0.000113	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—UPB1—autistic disorder	7.58e-05	0.000113	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—GSTM5—autistic disorder	7.56e-05	0.000113	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—ASMT—autistic disorder	7.56e-05	0.000113	CbGpPWpGaD
Cytarabine—SLC22A2—Neuronal System—PRKCB—autistic disorder	7.41e-05	0.000111	CbGpPWpGaD
Cytarabine—CDA—Metabolism—POMC—autistic disorder	7.36e-05	0.00011	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—TF—autistic disorder	7.35e-05	0.00011	CbGpPWpGaD
Cytarabine—DCK—Metabolism—CYP19A1—autistic disorder	7.15e-05	0.000107	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—SLC25A12—autistic disorder	7.11e-05	0.000106	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—COMT—autistic disorder	7.07e-05	0.000105	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—GSTM5—autistic disorder	7.05e-05	0.000105	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—ASMT—autistic disorder	7.05e-05	0.000105	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—GSTP1—autistic disorder	7.03e-05	0.000105	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—MAOA—autistic disorder	7.02e-05	0.000105	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—SLC19A1—autistic disorder	6.91e-05	0.000103	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—PRKCB—autistic disorder	6.91e-05	0.000103	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—CAT—autistic disorder	6.84e-05	0.000102	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—MAPK1—autistic disorder	6.72e-05	0.0001	CbGpPWpGaD
Cytarabine—DCK—Metabolism—COMT—autistic disorder	6.64e-05	9.92e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—SLC25A12—autistic disorder	6.63e-05	9.89e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—GSTP1—autistic disorder	6.61e-05	9.87e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—MAOA—autistic disorder	6.6e-05	9.85e-05	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—MAPK1—autistic disorder	6.49e-05	9.69e-05	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—GSTM1—autistic disorder	6.46e-05	9.65e-05	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PLA2G4A—autistic disorder	6.46e-05	9.65e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—SLC19A1—autistic disorder	6.45e-05	9.62e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—CAT—autistic disorder	6.43e-05	9.6e-05	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PTGS2—autistic disorder	6.42e-05	9.59e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—autistic disorder	6.3e-05	9.41e-05	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—GPX1—autistic disorder	6.19e-05	9.24e-05	CbGpPWpGaD
Cytarabine—POLA1—Mitotic M-M/G1 phases—MAPK1—autistic disorder	6.19e-05	9.23e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—ADSL—autistic disorder	6.16e-05	9.2e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—GSTM1—autistic disorder	6.08e-05	9.07e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PLA2G4A—autistic disorder	6.08e-05	9.07e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—XDH—autistic disorder	6.04e-05	9.02e-05	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—MAPK1—autistic disorder	6.01e-05	8.97e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—STX1A—autistic disorder	5.93e-05	8.86e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—NPAS2—autistic disorder	5.93e-05	8.86e-05	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PTGS2—autistic disorder	5.87e-05	8.77e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—GPX1—autistic disorder	5.82e-05	8.69e-05	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—MAPK1—autistic disorder	5.81e-05	8.67e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—ADSL—autistic disorder	5.74e-05	8.58e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—TCN2—autistic disorder	5.73e-05	8.55e-05	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—MTHFR—autistic disorder	5.71e-05	8.53e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—XDH—autistic disorder	5.63e-05	8.41e-05	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PTEN—autistic disorder	5.6e-05	8.36e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Biological oxidations—CYP19A1—autistic disorder	5.57e-05	8.31e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—STX1A—autistic disorder	5.53e-05	8.25e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—NPAS2—autistic disorder	5.53e-05	8.25e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metapathway biotransformation—CYP19A1—autistic disorder	5.49e-05	8.2e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—ADA—autistic disorder	5.47e-05	8.16e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—AVP—autistic disorder	5.46e-05	8.16e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—MTHFR—autistic disorder	5.37e-05	8.02e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—TCN2—autistic disorder	5.34e-05	7.97e-05	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—APOE—autistic disorder	5.32e-05	7.94e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Biological oxidations—COMT—autistic disorder	5.18e-05	7.73e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Biological oxidations—GSTP1—autistic disorder	5.15e-05	7.69e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Biological oxidations—MAOA—autistic disorder	5.14e-05	7.68e-05	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PTEN—autistic disorder	5.12e-05	7.65e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metapathway biotransformation—COMT—autistic disorder	5.11e-05	7.62e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—ADA—autistic disorder	5.09e-05	7.61e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—AVP—autistic disorder	5.09e-05	7.6e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metapathway biotransformation—GSTP1—autistic disorder	5.08e-05	7.59e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—APOE—autistic disorder	5e-05	7.46e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Transmission across Chemical Synapses—MAPK1—autistic disorder	4.98e-05	7.44e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—RORA—autistic disorder	4.98e-05	7.44e-05	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PIK3CG—autistic disorder	4.8e-05	7.16e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Biological oxidations—GSTM1—autistic disorder	4.74e-05	7.07e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—MAOB—autistic disorder	4.67e-05	6.97e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metapathway biotransformation—GSTM1—autistic disorder	4.67e-05	6.97e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Transmission across Chemical Synapses—MAPK1—autistic disorder	4.65e-05	6.94e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—RORA—autistic disorder	4.65e-05	6.94e-05	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—MAPK1—autistic disorder	4.63e-05	6.91e-05	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—POMC—autistic disorder	4.57e-05	6.82e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PIK3CG—autistic disorder	4.51e-05	6.73e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—INPP1—autistic disorder	4.43e-05	6.61e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—ACADSB—autistic disorder	4.43e-05	6.61e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—MAOB—autistic disorder	4.35e-05	6.5e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—TPH2—autistic disorder	4.34e-05	6.48e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—POMC—autistic disorder	4.29e-05	6.41e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—DPYD—autistic disorder	4.27e-05	6.38e-05	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—MAPK1—autistic disorder	4.14e-05	6.18e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—TPH2—autistic disorder	4.05e-05	6.04e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Transmission across Chemical Synapses—HRAS—autistic disorder	4e-05	5.97e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—DPYD—autistic disorder	3.98e-05	5.94e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—CACNA1C—autistic disorder	3.97e-05	5.93e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—BTD—autistic disorder	3.95e-05	5.9e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Neuronal System—MAPK1—autistic disorder	3.82e-05	5.7e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Transmission across Chemical Synapses—HRAS—autistic disorder	3.73e-05	5.57e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—CACNA1C—autistic disorder	3.7e-05	5.53e-05	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PTGS2—autistic disorder	3.64e-05	5.44e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—DHFR—autistic disorder	3.61e-05	5.39e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—MAPK1—autistic disorder	3.56e-05	5.31e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PTGS2—autistic disorder	3.43e-05	5.11e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—DHFR—autistic disorder	3.37e-05	5.03e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—TDO2—autistic disorder	3.36e-05	5.01e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Biological oxidations—POMC—autistic disorder	3.35e-05	5e-05	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PTEN—autistic disorder	3.18e-05	4.74e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—DHCR7—autistic disorder	3.16e-05	4.71e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Neuronal System—HRAS—autistic disorder	3.07e-05	4.58e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—SLC6A8—autistic disorder	2.99e-05	4.47e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—EXT1—autistic disorder	2.99e-05	4.47e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PTEN—autistic disorder	2.99e-05	4.46e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—HRAS—autistic disorder	2.86e-05	4.27e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—DAO—autistic disorder	2.86e-05	4.26e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—CYP19A1—autistic disorder	2.83e-05	4.22e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—UPB1—autistic disorder	2.74e-05	4.09e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—CYP19A1—autistic disorder	2.64e-05	3.94e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—COMT—autistic disorder	2.63e-05	3.93e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—GSTP1—autistic disorder	2.62e-05	3.91e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—MAOA—autistic disorder	2.61e-05	3.9e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—CAT—autistic disorder	2.55e-05	3.8e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—ASMT—autistic disorder	2.54e-05	3.8e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—GSTM5—autistic disorder	2.54e-05	3.8e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—COMT—autistic disorder	2.45e-05	3.66e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—GSTP1—autistic disorder	2.44e-05	3.64e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—MAOA—autistic disorder	2.43e-05	3.63e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—GSTM1—autistic disorder	2.41e-05	3.59e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PLA2G4A—autistic disorder	2.41e-05	3.59e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—SLC25A12—autistic disorder	2.39e-05	3.57e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—CAT—autistic disorder	2.37e-05	3.55e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—SLC19A1—autistic disorder	2.33e-05	3.47e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—GPX1—autistic disorder	2.3e-05	3.44e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PLA2G4A—autistic disorder	2.24e-05	3.35e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—GSTM1—autistic disorder	2.24e-05	3.35e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—GPX1—autistic disorder	2.15e-05	3.21e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—MTHFR—autistic disorder	2.13e-05	3.17e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—ADSL—autistic disorder	2.07e-05	3.1e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—XDH—autistic disorder	2.03e-05	3.04e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—STX1A—autistic disorder	2e-05	2.98e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—NPAS2—autistic disorder	2e-05	2.98e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—MTHFR—autistic disorder	1.98e-05	2.96e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—APOE—autistic disorder	1.98e-05	2.96e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—TCN2—autistic disorder	1.93e-05	2.88e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—APOE—autistic disorder	1.85e-05	2.75e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—ADA—autistic disorder	1.84e-05	2.75e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PIK3CG—autistic disorder	1.79e-05	2.67e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—POMC—autistic disorder	1.7e-05	2.54e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—RORA—autistic disorder	1.68e-05	2.5e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PIK3CG—autistic disorder	1.67e-05	2.49e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—POMC—autistic disorder	1.59e-05	2.37e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—MAOB—autistic disorder	1.57e-05	2.35e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—TPH2—autistic disorder	1.46e-05	2.18e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—DPYD—autistic disorder	1.44e-05	2.15e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PTGS2—autistic disorder	1.36e-05	2.03e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—CACNA1C—autistic disorder	1.34e-05	2e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PTGS2—autistic disorder	1.26e-05	1.89e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—DHFR—autistic disorder	1.22e-05	1.82e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PTEN—autistic disorder	1.18e-05	1.77e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PTEN—autistic disorder	1.1e-05	1.65e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—CYP19A1—autistic disorder	9.52e-06	1.42e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—COMT—autistic disorder	8.86e-06	1.32e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—GSTP1—autistic disorder	8.81e-06	1.32e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—MAOA—autistic disorder	8.79e-06	1.31e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—CAT—autistic disorder	8.58e-06	1.28e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PLA2G4A—autistic disorder	8.1e-06	1.21e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—GSTM1—autistic disorder	8.1e-06	1.21e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—GPX1—autistic disorder	7.76e-06	1.16e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—MTHFR—autistic disorder	7.16e-06	1.07e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—APOE—autistic disorder	6.66e-06	9.95e-06	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PIK3CG—autistic disorder	6.01e-06	8.98e-06	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—POMC—autistic disorder	5.72e-06	8.55e-06	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PTGS2—autistic disorder	4.57e-06	6.82e-06	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PTEN—autistic disorder	3.98e-06	5.94e-06	CbGpPWpGaD
